drugset / Trial / NCT05945498
Evaluation of ТВ/Flu-05Е Vaccine for the Prevention of Tuberculosis Infection in BCG-vaccinated Volunteers Aged 18-50 Years
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The aim of the study is to investigate safety, reactogenicity and immunogenicity of the TB/Flu-05E single-dose intranasal vaccine for the prevention of Tuberculosis infection in BCG-vaccinated Volunteers aged 18-50 years.
Timeline
- Start
- 2023-05-10
- Primary completion
- 2023-06-16
- Completion
- 2023-09-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TB/Flu-05E | Vaccine | 7.7 unknown | Intranasal |